Addex Therapeutics Ltd American Depositary Shares
N/A
USD
N/A
N/A
...
Chart
Financials
Description
ADXN Company Description
Addex Therapeutics Ltd is a clinical stage biopharmaceutical company. The company is focused on the development and commercialization of an emerging class of novel orally available small-molecule drugs known as allosteric modulators. The company's geographical area of operations includes Switzerland and Europe. The Company operates in one segment which is the discovery, development and commercialization of small-molecule pharmaceutical products.
ADXN Stock Smart Score
The Quiver Smart Score combines our data on Congress Trading, Lobbying, Insider Trading, CNBC Mentions and more to provide a comprehensive view of the strength of a stock's underlying data.
The Smart Score grades stocks on a scale of 1 (weakest) to 10 (strongest) based on the strength of the underlying data.
?
Sign Up to view ADXN Smart Score
Score Breakdown
Bull Case vs Bear Case
See concise summaries of analyst reports, presenting both bullish and bearish arguments for a stock.
Example:
Bulls Say:
The Bulls Say summary highlights positive aspects of the stock.
Bears Say:
The Bears Say summary points out potential risks and negative aspects of the stock.
Show More
All
Government
Consumer Interest
SEC Filings
ESG/Other
Recent trades of ADXN by members of U.S. Congress
Recently reported changes by institutional investors
Quarterly net insider trading by ADXN's directors and management
Government lobbying spending instances
U.S. Patents
New patents grants
Government Contracts
Federal grants, loans, and purchases
WallStreetBets
Number of mentions of ADXN in WallStreetBets Daily Discussion
ADXN News
Recent insights relating to ADXN
CNBC Recommendations
Recent picks made for ADXN stock on CNBC
Top ETF Holders
ETFs with the largest estimated holdings in ADXN
Corporate Flights
Flights by private jets registered to ADXN
Our Analysis